Analysis of the FAST™ system for expedited identification and antimicrobial susceptibility testing of bloodborne pathogens

Diagn Microbiol Infect Dis. 2022 Dec;104(4):115783. doi: 10.1016/j.diagmicrobio.2022.115783. Epub 2022 Jul 30.

Abstract

The high morbidity and mortality of sepsis can be impacted by expediting identification (ID) and antibiotic susceptibility testing (AST) of causative bacteria. We evaluated the Qvella FAST™ System which creates a Liquid Colony™ (LC) from blood cultures that can be used to expedite results by 24 to 48 hours. We analyzed 289 LC samples and found that there were 17 (5.9%) that resulted in no ID. One hundred percent of the LC samples that produced an ID were concordant with SOC identification. Gram-positive bacteria showed a categorical agreement (CA) of 99.5%, with 3 minor errors (minE), and no major errors (majE) or very major errors (VME), and essential agreement (EA) of 98.9%. For Gram-negatives, the CA was 97.8% and the EA was 98.5% with 31 minE, 0 majE, and 2 VME. The FAST-System™ can accelerate ID and AST by 24 to 48 hours with potential positive impacts on time to effective therapy for sepsis.

Keywords: Antimicrobial Susceptibilities; Fast; Liquid Colony; Pathogen Identification.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents*
  • Bacteremia* / diagnosis
  • Bacteremia* / drug therapy
  • Bacteremia* / microbiology
  • Blood Culture / methods
  • Blood-Borne Pathogens
  • Gram-Negative Bacteria
  • Gram-Negative Bacterial Infections* / microbiology
  • Humans
  • Microbial Sensitivity Tests
  • Sepsis* / diagnosis
  • Sepsis* / drug therapy
  • Sepsis* / microbiology

Substances

  • Anti-Infective Agents
  • Anti-Bacterial Agents